Abraxane (Paclitaxel protein-bound) for Breast Cancer | MyBCTeam

Connect with others who understand.

sign up Log in
About MyBCTeam
Powered By

Abraxane is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer after other treatments have failed. Abraxane may be also referred to by its drug name, paclitaxel protein-bound.

Abraxane is used as chemotherapy for breast cancer. Abraxane is a microtubule inhibitor and plant alkaloid. Abraxane is believed to work by interfering with cancer cell growth and division.

How do I take it?
Prescribing information states that Abraxane is administered via intravenous infusion every three weeks.

Abraxane comes in the form of a powder that is dissolved into an injectable suspension.

Side effects
The FDA-approved label for Abraxane lists common side effects including hair loss, numbness, fatigue, nausea, diarrhea, infections, anemia, decreased white blood cell count, and joint and muscle pain.

Rare but serious side effects listed for Abraxane include severe decreased blood cell count, severe nerve problems, serious infection, lung or breathing problems, and allergic reactions.

For more details about this treatment, visit:

Abraxane — Bristol Myers Squib

Abraxane — ChemoCare

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in